Skip to main content

OVARIAN CANCER BREAKTHROUGH BY QUEEN'S UNIVERSITY

EDM (Early Day Motion) 2699: tabled on 03 September 2019

Tabled in the 2017-19 session.

This motion has been signed by 17 Members. It has not yet had any amendments submitted.

Motion text

That this House congratulates all of those involved at Queens University, Belfast for its breakthrough early research findings on discovering a biomarker panel for ovarian cancer that may be able to detect epithelial ovarian cancer two years earlier than existing testing methods; thanks those who work so tirelessly to bring about such a difference to lives of people throughout the globe; and expresses pride in one of the foremost medical research universities in the world.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.